XML 44 R33.htm IDEA: XBRL DOCUMENT v3.19.2
Subsequent Event (Tables)
6 Months Ended
Jun. 30, 2019
Annual Purchase Requirements under Contract

 

2019

2.3 million

2020

15.9 million

2021

15.9 million

2022

19.8 million

2023

19.8 million

2024

8.6 million

 

Amended Insulin Supply Agreement  
Annual Purchase Requirements under Contract

On August 2, 2019, the Company and Amphastar amended the Insulin Supply Agreement to extend the term an additional two years (to December 31, 2026) and to restructure the annual purchase commitments as follows:

 

 

 

As of June 30, 2019

 

 

As amended August 2, 2019

 

2019

2.3 million

 

 

 

2020

15.9 million

 

6.6 million

 

2021

15.9 million

 

6.6 million

 

2022

19.8 million

 

8.5 million

 

2023

19.8 million

 

10.9 million

 

2024

8.6 million

 

14.6 million

 

2025

 

 

15.5 million

 

2026

 

 

19.4 million